Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Paediatrics and Child Heath

Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Paediatrics and Child Heath

Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): Royal College of Paediatrics and Child Heath
07 March 2013
(134.32 Kb 39 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 01 March 2013